Benjamin Gottlieb has been appointed partner of Schellenberg Wittmer as of 1 January 2023. He has extensive experience in arbitration and is an expert in the United Nations Convention on Contracts for the International Sale of Goods (
IMC, a global leader in market making, has entered into a definitive agreement to acquire the business of Tensor Technologies, a developer of trading software and algorithms, located in Zug, Switzerland. The transaction closed in
The owner of Plastic Surgery Group (PSG) has sold the company to Affidea Cancer Treatment Centres. Affidea is the leading provider of advanced diagnostic imaging, cancer therapies and outpatient services in Europe. With this transaction,
Niederer Kraft Frey advised Capvis, the specialist in mid-market investments and a well-known Swiss investor, on the investment into AdEx Partners. The growth strategy will be further enhanced through expansion of the service portfolio, internationalization,
Tiedemann Group, Alvarium Investments Limited and special purpose acquisition company Cartesian Growth Corporation announced that they have completed their previously announced business combination. The combined company now operates as Alvarium Tiedemann Holdings. AlTi is a
Biognosys and Bruker Corporation announced a strategic partnership, in which Bruker has made a majority-ownership investment in the company. Several of Biognosys’ earlier investors have sold their shares to Bruker in a secondary transaction, and
Niederer Kraft Frey has advised as lead counsel Capvis, the specialist in mid-market investments and a well-known Swiss investor, on the acquisition of a majority stake in SCHURTER Group. The closing is subject to (European)
Credit Suisse has successfully completed its issuance of GBP 500 m aggregate principal amount of 7.750 per cent. senior notes due 2026. The Notes were issued under Credit Suisse’s Euro Medium Term Note Programme. The Notes have
On January 5, 2023, BioVersys announced that the AMR Action Fund has joined existing investors of BioVersys, extending the total proceeds of the Series C round to CHF 32.6 million. The Swiss pharma company represents the first European-based
The first edition of “Mergers & Acquisitions” co-edited by Florian S. Jörg (partner at Bratschi, pictured left), Urs Gnos (partner at Walder Wyss, pictured center) and Schellenberg Wittmer corporate/m&a partner Lorenzo
